" /> CAPOX-Bevacizumab Regimen - CISMeF





Preferred Label : CAPOX-Bevacizumab Regimen;

NCIt synonyms : Capecitabine-Oxaliplatin-Bevacizumab Regimen; CAPOX-Avastin Regimen; CAPOX Plus Bevacizumab; B-CAPOX; CapeOx/Bevacizumab; CAPOX-B;

NCIt related terms : CapeOx and Bevacizumab; CapeOx and Bevacizumab-equi; CapeOx and Bevacizumab-bvzr; CapeOx and Bevacizumab-maly; CapeOx and Bevacizumab-adcd; CapeOx and Bevacizumab-awwb; CapeOx and Bevacizumab-aybi; CapeOx and Bevacizumab-onbe; CapeOx and Bevacizumab-tnjn;

NCIt definition : A regimen consisting of bevacizumab, capecitabine and oxaliplatin that may be used in the treatment of colorectal cancer, small bowel, appendiceal, and ampullary adenocarcinoma and mucinous carcinoma of the ovary.;

NCIt note : Source: NCCN Guidelines 2007;

Codes from synonyms : 14197; 127543; 127247; 127469; 127321; 127617; 127173; 127395; 142155;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.